These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 6421734)
21. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis. Shryock TR; Mollé JS; Klinger JD; Thomassen MJ J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922 [TBL] [Abstract][Full Text] [Related]
22. Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection. Martin C; Ohayon D; Alkan M; Mocek J; Pederzoli-Ribeil M; Candalh C; Thevenot G; Millet A; Tamassia N; Cassatella MA; Thieblemont N; Burgel PR; Witko-Sarsat V Am J Respir Cell Mol Biol; 2016 May; 54(5):740-50. PubMed ID: 26517580 [TBL] [Abstract][Full Text] [Related]
23. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis. Cowan RG; Winnie GB J Clin Immunol; 1993 Sep; 13(5):359-70. PubMed ID: 8245182 [TBL] [Abstract][Full Text] [Related]
24. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Bayer AS; Speert DP; Park S; Tu J; Witt M; Nast CC; Norman DC Infect Immun; 1991 Jan; 59(1):302-8. PubMed ID: 1898898 [TBL] [Abstract][Full Text] [Related]
25. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis. Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174 [TBL] [Abstract][Full Text] [Related]
26. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains. Baltimore RS; Mitchell M J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976 [TBL] [Abstract][Full Text] [Related]
27. Two distinct receptors mediate nonopsonic phagocytosis of different strains of Pseudomonas aeruginosa. Heale JP; Pollard AJ; Stokes RW; Simpson D; Tsang A; Massing B; Speert DP J Infect Dis; 2001 Apr; 183(8):1214-20. PubMed ID: 11262203 [TBL] [Abstract][Full Text] [Related]
28. Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose. Speert DP; Gordon S J Clin Invest; 1992 Sep; 90(3):1085-92. PubMed ID: 1522217 [TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases. Holby N; Olling S Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841 [TBL] [Abstract][Full Text] [Related]
30. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages. Barghouthi S; Everett KD; Speert DP J Immunol; 1995 Apr; 154(7):3420-8. PubMed ID: 7897223 [TBL] [Abstract][Full Text] [Related]
31. Phagocytosis of Pseudomonas aeruginosa by polymorphonuclear leukocytes and monocytes: effect of cystic fibrosis serum. Thomassen MJ; Demko CA; Wood RE; Sherman JM Infect Immun; 1982 Nov; 38(2):802-5. PubMed ID: 6815100 [TBL] [Abstract][Full Text] [Related]
32. Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis. Miller RV; Rubero VJ J Clin Microbiol; 1984 May; 19(5):717-9. PubMed ID: 6429192 [TBL] [Abstract][Full Text] [Related]
33. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay. Fick RB; Naegel GP; Matthay RA; Reynolds HY J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632 [TBL] [Abstract][Full Text] [Related]
34. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. Sajjan U; Reisman J; Doig P; Irvin RT; Forstner G; Forstner J J Clin Invest; 1992 Feb; 89(2):657-65. PubMed ID: 1737853 [TBL] [Abstract][Full Text] [Related]
35. Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients. Thomassen MJ; Demko CA Infect Immun; 1981 Aug; 33(2):512-8. PubMed ID: 6792079 [TBL] [Abstract][Full Text] [Related]
36. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. Wu H; Lee B; Yang L; Wang H; Givskov M; Molin S; Høiby N; Song Z FEMS Immunol Med Microbiol; 2011 Jun; 62(1):49-56. PubMed ID: 21303421 [TBL] [Abstract][Full Text] [Related]
37. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. Pier GB; Takeda S; Grout M; Markham RB J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038 [TBL] [Abstract][Full Text] [Related]
38. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. Bainbridge T; Fick RB J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365 [TBL] [Abstract][Full Text] [Related]
39. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Mahenthiralingam E; Campbell ME; Speert DP Infect Immun; 1994 Feb; 62(2):596-605. PubMed ID: 8300217 [TBL] [Abstract][Full Text] [Related]
40. Phagocytosis and intracellular killing of mucoid and nonmucoid Pseudomonas aeruginosa strains isolated from wounds of burned patients. Gościniak G; Ladosz J; Maresz-Babczyszyn J; Sokalska M Arch Immunol Ther Exp (Warsz); 1980; 28(4):619-23. PubMed ID: 6779776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]